Adaptive Biotechnologies
Translates a scale and precision of the adaptive immune system into products to diagnose and treat disease. Learn more
Launch date
Employees
Market cap
CAD927m
Enterprise valuation
CAD657m (Public information from Sep 2024)
Share price
$4.78 ADPT
Seattle Washington (HQ)
Authorizing premium user...